UTI Earnings Prediction
The chart below shows how UTI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, UTI sees a -2.54% change in stock price 10 days leading up to the earnings, and a +1.12% change 10 days following the report. On the earnings day itself, the stock moves by +0.47%. This data can give you a slight idea of what to expect for the next quarter's release.
UTI Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
196.36M
15.30%
10.65%
Gross Margin
49.40%
-33.21%
-35.94%
Operating Margin
13.25%
118.29%
215.48%
Net Margin
9.59%
143.40%
241.28%
EPS
0.33
230.00%
266.67%
No Data Available
UTI Earnings Analysis
Universal Technical Institute, Inc. Corporation (UTI.N) Earnings Conference Call
Positive
Q4 Revenue Surge: Revenue increased 15.3% to $196.4 million in Q4 2024, with Concorde contributing $65.8 million, a 19.7% increase year-over-year.
Annual Contribution Growth: Concorde's contribution for the full year was $246.3 million, a 38.3% increase over the prior year, while UTI contributed $486.4 million, representing a 13.3% increase.
Student Enrollment Surge: Total new student starts for fiscal 2024 exceeded expectations with 26,885 starts, including 11,492 in Q4, reflecting a 10.6% increase year-over-year.
Net Income Exceeds Guidance: Net income for the full year was $42 million, or $0.75 per diluted share, exceeding the upper end of guidance range.
EBITDA Improvement Highlights: Adjusted EBITDA improved significantly by 60% to $102.9 million for the full year, demonstrating strong operational performance.
Negative
Student Enrollment Surge: Total new student starts increased year-over-year by roughly 19% for the fiscal year, which exceeded the upper end of our guidance for the year.
Division Revenue Increases: Concorde contributed $246.3 million, an increase of 38.3% over the prior year, while the UTI division contributed $486.4 million, representing a 13.3% increase over the prior year.
Quarterly and Annual Net Income: Consolidated net income for the fourth quarter was $18.8 million or $0.34 per diluted share and $42 million or $0.75 per diluted share for the full year.
Strong Adjusted EBITDA Performance: Adjusted EBITDA for the fourth quarter was $37.3 million and $102.9 million for the full year, which exceeded the upper end of our guidance range.
Available Liquidity Overview: Total available liquidity at the end of the quarter was $230.9 million, including $69 million of remaining capacity on our revolving credit facility.
UTI FAQs
How does UTI typically perform around its earnings report dates?
Is Universal Technical Institute, Inc. (UTI) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
UTI Earning Call Sentiment
Universal Technical Institute, Inc. (UTI) Q4 2024 Earnings Call Transcript
1.0x
00:00
00:00
UTI.N
0.79%Positive
The earnings call reveals strong financial performance with a 21% revenue increase, improved net income, and robust adjusted EBITDA growth. Despite potential risks like supply chain disruptions and economic factors, the company provides optimistic guidance for 2025, driven by program expansions and increased marketing investments. The Q&A section indicates positive analyst sentiment, particularly regarding marketing and program additions. However, the absence of a shareholder return plan slightly tempers enthusiasm. Overall, the financial strength and growth prospects suggest a positive stock price reaction in the short term.